VLA 0.00% $1.75 viralytics limited

Ann: VLA to Present CAVATAK Clinical Data at Upcoming Conferences-VLA.AX, page-2

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 904 Posts.
    lightbulb Created with Sketch. 120
    Interesting 'poster' heading (p2), seems to allude some positive P2-CALM updates, good news...

    'Phase II CALM Extension study: Intratumoural Coxsackievirus A21 increases immune-cell infiltrates and up-regulates immunecheckpoint molecules in the tumour micro-environment'

    Bring on mid-October...

    ML
 
watchlist Created with Sketch. Add VLA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.